Es gab 50 kürzliche Insider-Transaktionen für Trevi Therapeutics, Inc. (TRVI), darunter 28 Käufe und 15 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $27.44M und die gesamten Insider-Verkäufe auf $20.37M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Good Jennifer L, Sciascia Thomas, Cassella James V. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — TRVI
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-02-19 |
Good Jennifer L |
President & CEO |
RSU-Zuteilung |
675,000 |
$10.56 |
$7.13M |
675,000 |
| 2026-02-19 |
Sciascia Thomas |
Chief Scientific Officer |
RSU-Zuteilung |
85,000 |
$10.56 |
$897.6K |
85,000 |
| 2026-02-19 |
Cassella James V |
Chief Development Officer |
RSU-Zuteilung |
215,000 |
$10.56 |
$2.27M |
215,000 |
| 2026-02-19 |
Galletta Christopher |
See Remarks |
RSU-Zuteilung |
35,000 |
$10.56 |
$369.6K |
35,000 |
| 2026-02-19 |
Simon Farrell |
Chief Commercial Officer |
RSU-Zuteilung |
160,000 |
$10.56 |
$1.69M |
160,000 |
| 2026-01-08 |
Hastings David C |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2026-01-08 |
Hastings David C |
Chief Financial Officer |
RSU-Zuteilung |
375,000 |
$11.21 |
$4.2M |
375,000 |
| 2025-12-31 |
Sandell Scott D |
10 Percent Owner |
Unbekannt |
- |
- |
- |
948,948 |
| 2025-12-31 |
Walker Paul Edward |
10 Percent Owner |
Unbekannt |
- |
- |
- |
948,948 |
| 2025-12-31 |
Florence Anthony A. Jr. |
10 Percent Owner |
Unbekannt |
- |
- |
- |
948,948 |
| 2025-12-31 |
Behbahani Ali |
10 Percent Owner |
Unbekannt |
- |
- |
- |
948,948 |
| 2025-12-31 |
Makhzoumi Mohamad |
10 Percent Owner |
Unbekannt |
- |
- |
- |
948,948 |
| 2025-12-31 |
Chang Carmen |
10 Percent Owner |
Unbekannt |
- |
- |
- |
948,948 |
| 2025-12-02 |
Galletta Christopher |
See Remarks |
Optionsausübung (Verkauf) |
4,225 |
$0.51 |
$2.16K |
15,775 |
| 2025-06-11 |
Vanlent Anne |
Director |
RSU-Zuteilung |
45,000 |
$6.25 |
$281.25K |
45,000 |
| 2025-06-11 |
Colangelo Dominick |
Director |
RSU-Zuteilung |
45,000 |
$6.25 |
$281.25K |
45,000 |
| 2025-06-11 |
Mathers Edward T |
Director |
RSU-Zuteilung |
45,000 |
$6.25 |
$281.25K |
45,000 |
| 2025-06-11 |
Meeker David P |
Director |
RSU-Zuteilung |
45,000 |
$6.25 |
$281.25K |
45,000 |
| 2025-06-11 |
Heffernan Michael Thomas |
Director |
RSU-Zuteilung |
45,000 |
$6.25 |
$281.25K |
45,000 |
| 2025-05-31 |
Good Jennifer L |
President & CEO |
RSU-Zuteilung |
102,000 |
$2.38 |
$242.76K |
156,400 |
| 2025-05-31 |
Sciascia Thomas |
Chief Scientific Officer |
RSU-Zuteilung |
60,000 |
$2.38 |
$142.8K |
92,000 |
| 2025-05-31 |
Galletta Christopher |
See Remarks |
RSU-Zuteilung |
8,550 |
$2.38 |
$20.35K |
13,110 |
| 2025-05-31 |
Delfini Lisa |
Chief Financial Officer |
RSU-Zuteilung |
72,000 |
$2.38 |
$171.36K |
110,400 |
| 2025-05-31 |
Simon Farrell |
Chief Commercial Officer |
RSU-Zuteilung |
72,000 |
$2.38 |
$171.36K |
110,400 |
| 2025-04-17 |
Sandell Scott D |
10 Percent Owner |
Optionsausübung (ITM) |
1,851,852 |
$1.37 |
$2.54M |
- |
| 2025-04-17 |
Baskett Forest |
10 Percent Owner |
Optionsausübung (ITM) |
1,851,852 |
$1.37 |
$2.54M |
- |
| 2025-04-17 |
Walker Paul Edward |
10 Percent Owner |
Optionsausübung (ITM) |
1,851,852 |
$1.37 |
$2.54M |
- |
| 2025-04-17 |
Florence Anthony A. Jr. |
10 Percent Owner |
Optionsausübung (ITM) |
1,851,852 |
$1.37 |
$2.54M |
- |
| 2025-04-17 |
Behbahani Ali |
10 Percent Owner |
Optionsausübung (ITM) |
1,851,852 |
$1.37 |
$2.54M |
- |
| 2025-04-17 |
Makhzoumi Mohamad |
10 Percent Owner |
Optionsausübung (ITM) |
1,851,852 |
$1.37 |
$2.54M |
- |
| 2025-04-17 |
New Enterprise Associates 16, L.p. |
10 Percent Owner |
Optionsausübung (ITM) |
1,851,852 |
$1.37 |
$2.54M |
- |
| 2025-04-17 |
Chang Carmen |
10 Percent Owner |
Optionsausübung (ITM) |
1,851,852 |
$1.37 |
$2.54M |
- |
| 2025-03-25 |
Sciascia Thomas |
Chief Scientific Officer |
Optionsausübung (Verkauf) |
2,631 |
$1.43 |
$3.76K |
- |
| 2025-03-21 |
Good Jennifer L |
President & CEO |
Optionsausübung (Verkauf) |
5,263 |
$1.43 |
$7.53K |
- |
| 2025-03-10 |
Good Jennifer L |
President & CEO |
RSU-Zuteilung |
54,400 |
$2.38 |
$129.47K |
54,400 |
| 2025-03-10 |
Sciascia Thomas |
Chief Scientific Officer |
RSU-Zuteilung |
32,000 |
$2.38 |
$76.16K |
32,000 |
| 2025-03-10 |
Galletta Christopher |
See Remarks |
RSU-Zuteilung |
4,560 |
$2.38 |
$10.85K |
4,560 |
| 2025-03-10 |
Delfini Lisa |
Chief Financial Officer |
RSU-Zuteilung |
38,400 |
$2.38 |
$91.39K |
38,400 |
| 2025-03-10 |
Simon Farrell |
Chief Commercial Officer |
Optionsausübung (Verkauf) |
17,500 |
$3.21 |
$56.18K |
- |
| 2025-02-18 |
Good Jennifer L |
President & CEO |
RSU-Zuteilung |
811,000 |
$4.22 |
$3.42M |
811,000 |
| 2025-02-18 |
Sciascia Thomas |
Chief Scientific Officer |
RSU-Zuteilung |
116,000 |
$4.22 |
$489.52K |
116,000 |
| 2025-02-18 |
Cassella James V |
Chief Development Officer |
RSU-Zuteilung |
257,500 |
$4.22 |
$1.09M |
257,500 |
| 2025-02-18 |
Galletta Christopher |
See Remarks |
RSU-Zuteilung |
41,000 |
$4.22 |
$173.02K |
41,000 |
| 2025-02-18 |
Delfini Lisa |
Chief Financial Officer |
RSU-Zuteilung |
225,500 |
$4.22 |
$951.61K |
225,500 |
| 2025-02-18 |
Simon Farrell |
Chief Commercial Officer |
RSU-Zuteilung |
225,500 |
$4.22 |
$951.61K |
225,500 |
| 2025-01-08 |
Delfini Lisa |
Chief Financial Officer |
Optionsausübung (Verkauf) |
5,000 |
$0.51 |
$2.56K |
42,125 |
| 2025-01-07 |
Delfini Lisa |
Chief Financial Officer |
Optionsausübung (Verkauf) |
1,000 |
$0.51 |
$511.00 |
47,125 |
| 2024-12-13 |
Galletta Christopher |
See Remarks |
Optionsausübung |
15,000 |
$0.51 |
$7.67K |
19,935 |
| 2024-09-30 |
Cassella James V |
Chief Development Officer |
RSU-Zuteilung |
400,000 |
$3.34 |
$1.34M |
400,000 |
| 2024-09-09 |
Good Jennifer L |
President & CEO |
Optionsausübung (Verkauf) |
1,840 |
$1.43 |
$2.63K |
- |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
